M. Funaba et al., FOLLISTATIN AND ACTIVIN IN BONE - EXPRESSION AND LOCALIZATION DURING ENDOCHONDRAL BONE-DEVELOPMENT, Endocrinology, 137(10), 1996, pp. 4250-4259
The involvement of activin and follistatin, an activin-binding protein
, in endochondral bone development was examined by sc implantation of
demineralized bone matrix in rats. Immunoreactive follistatin was loca
lized in proliferating chondrocytes and round osteoblasts, whereas it
was not detected in hypertrophic chondrocytes and osteoblasts surround
ing bone marrow. Western blot analysis also revealed that immunoreacti
ve follistatin was higher during the initial stages of chondrogenesis
(day 5) and osteogenesis (days 11 and 14) and lower during tile conver
sion from cartilage to bone (day 9). These results suggest that follis
tatin is produced by proliferating cells, and the expression decreases
with differentiation of the cells. Implants injected with follistatin
on days 9 and 10 contained lower calcium levels on day 14 than those
injected with rat albumin. Furthermore, the follistatin-injected impla
nts were still mainly composed of cartilage, ting that the disappearan
ce of follistatin is necessary for the conversion of cartilage to bone
. In contrast, immunoreactive activin beta(A) (55-60 kDa) was continuo
usly detected in implants on days 7-14. The content of C propeptide of
type II procollagen was increased and cartilageous area was enlarged
on day 7 by activin A injections on days 5 and 6. suggesting a chondro
genic effect of activin in the initial stage of cartilage formation. T
hese results indicate that proliferating chondrocytes and round osteob
lasts produce follistatin, and that the activity of activin is regulat
ed by changes in the expression of follistatin at the stages of chondr
ogenesis and transition from cartilage to bone.